cdmo.directory
← Compare landing

Grand River Aseptic Manufacturing vs Samsung Biologics

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryGrand River Aseptic ManufacturingSamsung Biologics
SummarySterile injectable CDMO specializing in fill-finish services for liquid and lyophilized vials, syringes, and cartridges, with Annex 1 compliant facilities and experience in biologics, small molecules, and vaccines.Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • Controlled Substance Manufacturing
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Cartridge Filling
  • Lyophilization (Freeze Drying)
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • Secondary Packaging & Labeling
  • Serialization & Track-and-Trace
  • CMC Regulatory Submission Support
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • mRNA Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Cartridge Filling
  • Lyophilization (Freeze Drying)
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Vaccine
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • mRNA
  • Vaccine
Development capabilities
  • Analytical method development
  • ICH stability testing
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Prefilled Syringes (PFS)
  • Cartridges
  • DEA licensed
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Prefilled Syringes (PFS)
  • Cartridges
  • Max bioreactor: Large commercial (≤10,000 L)
  • Expression: Mammalian
  • Expression: Cell-Free
  • Single-Use / Disposable
  • Stainless Steel
Locations
  • Headquarters, Grand Rapids, Michigan, United States
  • Headquarters
  • Bio Campus I, South Korea
  • Bio Campus II, South Korea
  • Headquarters / Bio Campus I, Incheon, Yeonsu-gu, Republic of Korea
  • Bio Campus II, Incheon, Yeonsu-gu, Republic of Korea
  • ADC Plant, Incheon, Yeonsu-gu, Republic of Korea
  • Samsung Biologics America, United States
  • Samsung Biologics Japan Office, Japan
  • Headquarters
Certifications
  • GMP · Identifier: Five GMP manufacturing facilities
  • Annex 1 · Identifier: Three facilities designed and qualified with Annex 1 revisions
  • GMP · Identifier: Five GMP manufacturing facilities; three Annex 1 compliant
  • FDA · Identifier: GMP
  • EMA · Identifier: Annex 1
  • GMP · Identifier: Five GMP manufacturing facilities (three Annex 1 compliant)
Data not yet provided.

Find similar companies

Grand River Aseptic Manufacturing alternatives · Samsung Biologics alternatives

Markdown mirror: /compare/grandriverasepticmfg/samsungbiologics.md